Omega Diagnostics shares have risen significantly on news that the Mologic’s Covid-19 lab-based antibody test it agreed to manufacture at scale has received the CE-mark.
Pending final validation by Public Health England, NHS Scotland and also in the Republic of Ireland, Omega is ready to scale up production of this test and has the supply chains to do so to make 46,000 Covid-19 tests per day.
The CE-mark - ensuring a product complies with EU safety, health and environmental requirements - follows successful independent validation of Mologic’s Elisa test by the Liverpool School of Tropical Medicine and St George’s, University of London.
READ MORE: Omega Diagnostics gears up for mass roll-out of virus testing kits
Clackmannanshire-based Omega will use its Elisa manufacturing facility in Littleport, Cambridgeshire to manufacture the tests.
Omega and Mologic will now finalise a longer-term supply agreement to commercialise this test which will be used on patient samples sent by hospitals or GPs for laboratory testing.
Partnering with Mologic is separate from, and additional to, the announcement made by the Company on April 9 2020 relating to the UK Rapid Test Consortium (RTC), which is to jointly develop and manufacture a Point-of-Care Covid-19 lateral flow antibody test which could be used "at-home" and which will be manufactured in Omega’s Alva facility in Scotland.
Colin King, CEO of Omega said: “We are pleased that Omega has been able to CE-Mark Mologic’s Elisa antibody test and it is testimony to the teams within both companies that we have reached this milestone in such a short timescale.”
Shares were up 38.16% to 52.5p, up 14.5p.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article